Groupe Santé Devonian reçoit l’avis d’acceptation pour le brevet canadien de son traitement anti-âge Purgenesis(MC)
May 16, 2018 08:45 ET
|
Groupe Santé Devonian Inc.
QUÉBEC, 16 mai 2018 (GLOBE NEWSWIRE) -- Groupe Santé Devonian inc. (« Devonian » ou la « Société ») (TSX CROISSANCE:GSD) annonçait aujourd’hui avoir reçu un avis d’acceptation de l’Office de la...
Devonian Health Group Announces Canadian Patent for its Purgenesis™ anti-aging treatment
May 16, 2018 08:45 ET
|
Devonian Health Group Inc.
QUEBEC CITY, May 16, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSX VENTURE:GSD) today announced that the Canadian Intellectual Property Office issued a...
Devonian annonce le dépôt d'une nouvelle demande de brevet pour le Thykamine(MC)
November 16, 2017 20:45 ET
|
Groupe Santé Devonian Inc.
NE PAS DISTRIBUER AUX AGENCES DE PRESSE AMÉRICAINES NI DIFFUSER AUX ÉTATS-UNIS QUÉBEC, 16 nov. 2017 (GLOBE NEWSWIRE) -- Groupe Santé Devonian Inc. (« Devonian » ou la « Société ») (TSX...
Devonian Announces the Filing of New Patent Application for Thykamine™
November 16, 2017 20:45 ET
|
Devonian Health Group Inc.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES QUEBEC CITY, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. ("Devonian" or the "Corporation")...
Quest Obtains an Extension of the Delay to File a Proposal Under the Bankruptcy and Insolvency Act (Canada)
August 04, 2017 17:35 ET
|
Quest Rare Minerals Ltd.
MONTREAL, Aug. 04, 2017 (GLOBE NEWSWIRE) -- Quest Rare Minerals Ltd. (TSX:QRM) announced that on August 3, 2017, the Superior Court of Québec granted Quest Rare Minerals’ motion for an extension of...
Quest Obtains International Patent for its Selective Thermal Sulphation Process
June 28, 2017 19:58 ET
|
Quest Rare Minerals Ltd.
MONTREAL, June 28, 2017 (GLOBE NEWSWIRE) -- Quest Rare Minerals Ltd. (TSX:QRM) (Quest) is pleased to announce that it has obtained issuance of international patent (PCT/CA2016/051489) from the World...